Copy of `AGNIC - Wildlife terms`
The wordlist doesn't exist anymore, or, the website doesn't exist anymore. On this page you can find a copy of the original information. The information may have been taken offline because it is outdated.
|
|
AGNIC - Wildlife terms
Category: Animals and Nature > Wildlife Management
Date & country: 27/09/2013, USA Words: 917
|
diagnosisthe determination of the existence of a disease or condition. Diagnosis generally involves an evaluation of a person's medical history, clinical symptoms, and laboratory test results.
dialysisa method for filtering waste from the blood that replaces the function of the kidneys that are not working properly.
diarrheafrequent, loose bowel movements. Diarrhea may be caused by a variety of factors, including microorganisms and as a side effect of certain drugs. Persistent diarrhea can lead to dehydration and inadequate nutrient absorption.
didanosine (ddi, ddi)an HIV medication (brand name VIDEX and VIDEX EC). It is a reverse transcriptase inhibitor, used in combination with other antiretroviral drug therapy as part of active antiretroviral therapy (ART). Ribavirin should be avoided if DDI is being used to treat HIV due to the risk of developing lactic acidosis.
dietitiana medical professional specializing in dietetics, the study of nutrition and the use of special diets to prevent and treat disease.
digestive systemthe organs (mouth, pharynx, esophagus, stomach, small intestine, large intestine, and anus) associated with ingestion and digestion of food.
direct-acting antivirals (daathere are at least 4 categories of direct antivirals
discordantnot having the same serostatus, for example a couple in which one partner is HCV positive and the other is HCV negative.
diuretican agent that increases loss of water from the body through urination.
dmsee diabetes mellitus.
dnasee deoxyribonucleic acid.
dosagethe amount of a drug that is given at one time.
dose-ranging triala clinical trial in which different doses of a drug are compared to determine which dosage has the best balance of effectiveness and acceptable side effects.
doshaone of the three bodily humors (vata, pitta, and kapha,) recognized in Ayurvedic medicine.
double-blindsee blinding.
drug resistancethe loss of drug effectiveness of a drug that had previously been able to control or kill an organism such as a virus.
drug-drug interaction (ddi)a reaction that can occur when multiple drugs are taken together or drugs are taken with certain herbs or foods. Drug interactions may enhance or reduce the action of a drug and may increase its side effects, and could potentially cause life-threatening reactions.
dxabbreviation for diagnosis.
dysfunctionlack or loss of normal function.
dysplasia (adjective dysplastic)abnormal cell or tissue growth.
dysthymiasee depression.
early virological response (evr)2 log10 drop in HCV RNA at treatment week 12.
eczemaa type of skin rash.
edemaswelling caused by accumulation of fluid in body tissues.
efficacyeffectiveness; the ability to achieve a desired result.
eligibility criteriathe criteria of a clinical trial that includes inclusion and exclusion criteria.
elisa/elisa iisee enzyme-linked immunosorbent assay.
embolisma blood clot that travels through the bloodstream and becomes lodged in a blood vessel, causing a blockage.
empiricalinformation based on data, not on a theory.
encephalopathydisease of the brain. See also hepatic encephalopathy.
end-stage renal disease (esrd)kidney failure.
endocrineendocrine glands are ductless glands that regulate bodily functions via hormones secreted into the bloodstream. The endocrine system includes the hypothalamus, pituitary gland, thyroid, adrenal glands, and gonads (ovaries and testes).
endoscopya method of examining the interior of a body cavity or hollow organ (e.g., esophagus, stomach) using an endoscope, a narrow, flexible fiber optic instrument that conducts light.
endothelium (adjective endothelial)a layer of cells that lines blood and lymph vessels, the heart, and various body cavities.
endpointa marker of disease progression or treatment outcome. Endpoints may be clinical manifestations (e.g., disease symptoms, death) or laboratory results such as ALT level or viral load (sometimes called surrogate markers). An endpoint of a clinical trial is the outcome
enrollment criteriafactors used to determine whether a person is eligible to participate in a clinical trial. See also inclusion criteria, exclusion criteria.
entecavir (brand name baraclude)A nucleoside analogue produced by Bristol-Myers Squibb that is used to treat chronic hepatitis B. It is recommended as a first line of treatment except in people who have developed lamivudine resistance.
enterichaving to do with the intestines.
enteric hepatitissee hepatitis E.
envelopethe outer coat of a virus.
enzymea protein that induces or accelerates a chemical reaction.
eotsee end-of-treatment response.
epidemiologythe study of the frequency, distribution, and behavior of a disease within a population.
epivirsee lamivudine.
eposee erythropoietin.
epogensee erythropoietin.
eradication (verb eradicate)the complete elimination of an organism from the body.
erythrocytea mature red blood cell. Erythrocytes transport oxygen to the tissues of the body.
erythropoietin (epoietin, epo)a hormone produced by the kidneys that stimulates the production of red blood cells. Genetically engineered EPO (brand names Procrit, Epogen) is used to treat certain types of anemia.
esophagus (adjective esophageal)the swallowing tube; the portion of the digestive tract between the mouth and the stomach.
esrdsee end-stage renal disease.
essential mixed cryoglobulinemiasee cryoglobulinemia.
estrogenthe primary female sex hormone or a synthetic analog. Estrogens stimulate the development of female secondary sex characteristics and regulate the reproductive cycle in women.
etiologythe cause of a disease.
evrsee early virological response.
exacerbateto worsen or make more severe.
exclusion criteriaconditions that disqualify someone from participating in a clinical trial. Contrast with inclusion criteria.
expanded accessthe distribution of an investigational medication to those who are in highest need and who may not qualify for the drug in clinical trials.
experimental armthe group of participants in a clinical trial that receives the new experimental treatment under study.
experimental druga new drug that is being tested as a treatment for a specific condition and has not yet been approved by the FDA for use.
extrahepaticoutside the liver.
factor viiia protein synthesized by the liver that is necessary for proper blood clotting.
failure to thrivea condition in which an infant loses or fails to gain weight and develops at a slower rate than expected.
false-negativea negative test result in a person who has the disease or condition being tested. Contrast with false-positive.
false-positivea positive test result in a person who does not have the disease or condition being tested. Contrast with false-negative.
fasciculationan involuntary muscle contraction.
fast tracka designation by the Food and Drug Administration to help facilitate the development and to expedite the review process for an experimental drug that has the potential to address an unmet medical need for a serious or life-threatening condition.
fat-solublecapable of being dissolved in fat. Contrast water-soluble.
fatigueunusual, prolonged, or excessive tiredness.
fatty acidan organic molecule made up of a hydrocarbon chain and a carboxylic acid group. Fatty acids may be saturated, monounsaturated, or polyunsaturated.
fdasee Food and Drug Administration.
febrilehaving a fever or increased body temperature.
fecal-oral routea route of transmission of infectious organisms which involves the transfer of fecal matter to the mouth
feces (adjective fecal)excrement; excreted waste matter.
fellatiooral sex on a man; contact between the mouth and the penis.
female condomsee condom.
fibrinogena factor produced by the liver that is necessary for proper blood clotting.
fibromyalgia (fibromyositis)a condition characterized by pain throughout the body, often accompanied by fatigue.
fibrosis (adjective fibrotic)liver damage in which fibrous tissue develops and replaces normal cells.
filgrastimsee granulocyte colony-stimulating factor.
fine-needle aspiration biopsya type of liver biopsy in which a tissue sample is withdrawn using a very fine needle.
flare (flare-up)a sudden, acute worsening of disease symptoms.
flatulenceexcessive intestinal gas.
flavivirusa group of viruses, several of which cause diseases in humans. HCV is related to flaviviruses, and some taxonomists consider the Hepacivirus genus to be part of the Flaviviridae family.
flumadinesee rimantadine.
folic acid (folate)a vitamin necessary for red blood cell production and proper neurological function; folic acid also helps prevents neural tube defects in fetuses.
food and drug administration (fda)the U.S. federal agency responsible for regulating the development, use, and safety of drugs, medical devices, cosmetics, and related products. The FDA approves new experimental drugs based on the results of clinical trials.
fribromyositissee fibromyalgia.
fulminantan unusually severe or aggressive form of a disease.
fulminant hepatitisa severe, life-threatening form of hepatitis.
gall bladderan organ beneath the liver where bile is stored.
gamma globulina preparation of antibodies injected to prevent or treat infection. Gamma globulin is used as post-exposure prevention for hepatitis A and hepatitis B.
gamma-glutamyl transpeptidase (ggt)a liver enzyme. Elevated GGT levels may indicate bile obstruction and liver damage. A normal GGT level is 30 to 60 IU/L.
gan caosee licorice root.
gastroenteritisinflammation of the stomach and intestines.
gastrointestinalhaving to do with the digestive system, especially the stomach and intestines.
gastrointestinal tractthe digestive tube consisting of the mouth, esophagus, stomach, small intestine, large intestine, and anus.
gb virus c (gbv-c)see hepatitis G virus.
gene therapyan approach to preventing or treating disease by replacing, removing, or introducing genes, or otherwise manipulating genetic material.
generic druga drug that is not protected by a patent and may be produced by any manufacturer.